Lowering Rituximab Dose in Patients With MS Safe, Effective Lowering Rituximab Dose in Patients With MS Safe, Effective

A new study has found that reducing rituximab dosage from 1,000 mg every 6 months to 500 mg every 6 months is a safe and stable choice for patients with multiple sclerosis.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news